Clinical Trials Browser

Terminated × NIH × Erlotinib Hydrochloride × Clear all

NCT02169284 2020-07-07

Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery

Phase 2 Terminated

50 enrolled 27 charts

Urinary Bladder Neoplasms

NCT01822496 2019-08-05

Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Phase 2 Terminated

59 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT00096265 2018-03-09

Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

Phase 3 Terminated

126 enrolled 14 charts

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00738881 2015-10-29

MARVEL

Phase 3 Terminated

23 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung

NCT02134886 2015-10-06

Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, HIV Infections

NCT01193881 2015-09-29

RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung

NCT01013831 2015-02-18

Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung

Phase 1 Terminated

Metaplasia

NCT00482625 2014-10-16

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Phase 2 Terminated

6 enrolled 8 charts

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT00976677 2014-05-30

Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

10 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung

NCT00087269 2013-06-06

Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00042835 2013-02-01

Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer

Phase 1 Terminated

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00047333 2013-01-23

Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed

Phase 2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular